{"entity":{"type":"insider","cik":"0001632798","url":"/insider/0001632798","json_url":"/insider/0001632798.json","name":"Monnet Dominique","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":3,"first":"2015-02-12","last":"2020-12-17","span_basis":"filed_date"},"name_variants":[{"name":"Monnet Dominique","source":"filing","n_filings":3,"first_seen":"2015-02-12","last_seen":"2020-12-17"}],"transactions":[{"id":3109897,"accession":"0000882104-20-000210","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000882104-20-000210","line_url":"/filing/0000882104-20-000210#line-1","is_derivative":false,"issuer_cik":"0000882104","issuer_name":"PDL BIOPHARMA, INC.","issuer_ticker":"PDLI","issuer_name_source":null,"issuer_url":"/issuer/0000882104","owner_cik":"0001632798","owner_name":"Monnet Dominique","owner_url":"/insider/0001632798","role":"Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500000.0,"shares_display":"500,000","price_per_share":2.6,"price_display":"2.60","price_state":"stated","total_value":1300000.0,"total_display":"1,300,000.00","shares_owned_after":734921.0,"shares_owned_after_display":"734,921","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-16","filed_date":"2020-12-17","scope":"insider"},{"id":8807348,"accession":"0000899866-15-000124","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-15-000124","line_url":"/filing/0000899866-15-000124#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001632798","owner_name":"Monnet Dominique","owner_url":"/insider/0001632798","role":"Officer (SVP, Chief Marketing Officer)","officer_title":"SVP, Chief Marketing Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":256.0,"shares_display":"256","price_per_share":162.4,"price_display":"162.40","price_state":"stated","total_value":41574.4,"total_display":"41,574.40","shares_owned_after":8787.0,"shares_owned_after_display":"8,787","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-20","filed_date":"2015-05-22","scope":"insider"},{"id":8482434,"accession":"0000899866-15-000053","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-15-000053","line_url":"/filing/0000899866-15-000053#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001632798","owner_name":"Monnet Dominique","owner_url":"/insider/0001632798","role":"Officer (SVP, Chief Marketing Officer)","officer_title":"SVP, Chief Marketing Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":325.0,"shares_display":"325","price_per_share":171.15,"price_display":"171.15","price_state":"stated","total_value":55623.75,"total_display":"55,623.75","shares_owned_after":5213.0,"shares_owned_after_display":"5,213","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-10","filed_date":"2015-02-12","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000882104","name":"PDL BIOPHARMA, INC.","url":"/issuer/0000882104","role":"Officer (President and CEO)","n_filings":1,"first_seen":"2020-12-17","last_seen":"2020-12-17"},{"type":"issuer","type_label":"ISSUER","cik":"0000899866","name":"ALEXION PHARMACEUTICALS INC","url":"/issuer/0000899866","role":"Officer (SVP, Chief Marketing Officer)","n_filings":2,"first_seen":"2015-02-12","last_seen":"2015-05-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001632798","retrieved_at":"2026-08-20T19:32:46+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}